You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
Register for free to read this article
As a service to the community, this article is available for free. Existing users log in.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Guiding Malaria Chemoprevention
Piperaquine (PQ) is a long-acting antimalarial drug used in combination with short-acting dihydroartemisinin (DHA) to treat and prevent malaria infections. PQ blood measurement and malaria infection data were collected after monthly or bimonthly standard 3-day treatment regimens of DHA-PQ. Bergstrand et al. then used these data to develop a mathematical model to characterize the relationship between PQ blood concentrations and the risk of acquiring a malaria infection. PQ concentrations of 6.7 and 20 ng/ml were found to reduce the risk of acquiring a malaria infection by 50 and 95%, respectively. The model was used to predict the expected outcome in vulnerable populations such as children and pregnant women living in malaria endemic areas.
- Copyright © 2014, American Association for the Advancement of Science
